Ever since the launch of its operations in 2016, the McPeak-Sirois Group has been working in Quebec to increase both the number of available breast cancer clinical trials, the number of hospitals that offer these trials and the number of patients who participate in them. Efficiency in starting studies is also one of the desired benefits.
The McPeak-Sirois Group is:
- A unique consortium of nine hospital centers covering approximately 4,000 new cases of breast cancer that occur annually, which represents at present more than 60% of all new annual cases in Quebec.
Other hospital centers throughout Quebec will be added in the coming months to ensure clinical trials are offered to even more patients.
We cover 60% of new cases in Quebec
- Several clinical trials started as a consortium in partnership with about twenty pharmaceutical companies and collaborative groups.
We are in constant discussion with our partners for the conduct of new trials.
- More than 300 people included in clinical trials to date.
- Operational harmonization that reduces time at each stage of study implementation for a start-up target of 120 days.